Clinical Trials with Melleril (TP21) in the Treatment of Schizophrenia
- 1 April 1960
- journal article
- Published by Royal College of Psychiatrists in Journal of Mental Science
- Vol. 106 (443) , 732-741
- https://doi.org/10.1192/bjp.106.443.732
Abstract
The authors undertook to investigate the effects of two new phenothiazine derivatives on schizophrenic patients. Over a period of two years a series of clinical trials have been carried out on approximately 260 patients, some controlled, some uncontrolled. These drugs, known as Melleril (TP21) and KS75 are chemically related. Although Melleril was ultimately selected as the drug of choice we have, for statistical reasons, included some of the findings with KS75.Keywords
This publication has 4 references indexed in Scilit:
- Differential Analysis of the Effects of Phenothiazine-Tranquillizers on Emotional and Motor Behaviour in Experimental AnimalsNature, 1959
- NEWER PHENOTHIAZINE DRUGS IN TREATMENT OF NERVOUS DISORDERSJAMA, 1959
- TP-21, A NEW PHENOTHIAZINEAmerican Journal of Psychiatry, 1958
- Clinical Research in PsychiatryJournal of Mental Science, 1958